Here's the List

Total Page：16

File Type：pdf, Size：1020Kb

List of Genetically Modified Organisms for 8th grade research project May 2017 1. lavender-colored carnations- http://en.wikipedia.org/wiki/Dianthus_caryophyllus#Colors 2. blue roses- http://en.wikipedia.org/wiki/Blue_rose 3. glowing fish- http://en.wikipedia.org/wiki/GloFish 4. golden rice- http://en.wikipedia.org/wiki/Golden_rice 5. salmon- http://en.wikipedia.org/wiki/Genetically_modified_salmon 6. insect- http://en.wikipedia.org/wiki/Genetically_modified_insect 7. MON 810- http://en.wikipedia.org/wiki/MON_810 8. Amflora- http://en.wikipedia.org/wiki/Amflora 9. Roundup Ready Soybean- http://en.wikipedia.org/wiki/Roundup_ready_soybean 10. Flavr Savr- http://en.wikipedia.org/wiki/Flavr_savr 11. Wheat- http://en.wikipedia.org/wiki/Genetically_modified_wheat 12. Mouse- http://en.wikipedia.org/wiki/Knockout_mouse 13. Pig- http://en.wikipedia.org/wiki/Enviropig 14. Bull- http://en.wikipedia.org/wiki/Herman_the_Bull 15. Sheep- http://en.wikipedia.org/wiki/Dolly_the_sheep 16. Ice-minus bacteria- http://en.wikipedia.org/wiki/Ice-minus_bacteria 17. supermice- http://en.wikipedia.org/wiki/Metabolic_supermice 18. oncomouse- http://en.wikipedia.org/wiki/Oncomouse 19. rat- http://en.wikipedia.org/wiki/Knockout_rat 20. goats- http://en.wikipedia.org/wiki/BioSteel 21. green fluorescence- http://en.wikipedia.org/wiki/Green_fluorescent_protein 22. Ruppy- http://en.wikipedia.org/wiki/Ruppy 23. mosquito- http://en.wikipedia.org/wiki/Aedes_aegypti 24. corn- http://en.wikipedia.org/wiki/SmartStax 25. poplar tree- http://en.wikipedia.org/wiki/Genetically_modified_tree 26. dog- http://en.wikipedia.org/wiki/Snuppy 27. rice fish- http://en.wikipedia.org/wiki/Oryzias_latipes 28. medicine- http://en.wikipedia.org/wiki/ATryn 29. papaya- http://en.wikipedia.org/wiki/Carica_papaya 30. apples- http://en.wikipedia.org/wiki/Nonbrowning_Arctic_Apples 31. sugar beet- http://en.wikipedia.org/wiki/Sugar_beet#Genetic_modification 32. starlink corn- http://en.wikipedia.org/wiki/Starlink_corn_recalls 33. cat- http://en.wikipedia.org/wiki/CC_(cat) 34. monkey- http://en.wikipedia.org/wiki/Tetra_(monkey) 35. polly and molly- http://en.wikipedia.org/wiki/Polly_and_Molly 36. Idaho gem- http://en.wikipedia.org/wiki/Idaho_Gem 37. Zorse- http://en.wikipedia.org/wiki/Zebroid#Genetics 38. Rat- http://en.wikipedia.org/wiki/Ralph_(rat) 39. Horse- http://en.wikipedia.org/wiki/Prometea 40. Gaur- http://en.wikipedia.org/wiki/Noah_(gaur) 41. cloning law- http://en.wikipedia.org/wiki/Human_cloning#United_States 42. bacteria- https://en.wikipedia.org/wiki/Genetically_modified_bacteria .

Copy Link

Recommended publications

The Patentability of Synthetic Organisms
Creating Life from Scratch: The Patentability of Synthetic Organisms Michael Saunders* I. INTRODUCTION ................................................................................... 75 II. PATENTING MICROBIAL LIFE—CHAKRABARTY ................................ 77 III. PATENTING MULTICELLULAR LIFE—HARVARD ONCOMOUSE .......... 80 IV. IMPLICATIONS FOR SYNTHETIC BIOLOGY .......................................... 83 A. Single-Celled Synthetic Organisms ......................................... 83 B. Multicellular Synthetic Organisms .......................................... 86 V. CONCLUSIONS ..................................................................................... 88 I. INTRODUCTION Published in May 2007, U.S. application no. 20070122826 (Venter patent) describes a minimally operative genome of the bacterium Mycoplasma genitalium consisting of 381 genes, which the inventors believe to be essential for the survival of the bacterium in an environment containing all the necessary nutrients and free from stress.1 However, the team of inventors from the J. Craig Venter Institute is trying to accomplish something more than just the usual patenting of genes; they intend to create and patent the world’s first artificial organism. The team has already cleared two of the three major hurdles on its way to constructing this first synthetic organism. In January 2008, they announced completion of the second step, the laboratory synthesis of the entire 582,970 base pairs of the genome described in the patent above.2 What remains is the third and final step of inserting this human-made genome into a bacterial cell chassis and “booting up” the organism.3 Craig Venter and Hamilton Smith, lead researchers on the team have been discussing the creation of synthetic life since 1995, when their team published the first complete genome sequence of a living * © 2008 Michael Saunders. J.D. candidate 2009, Tulane University School of Law; B.S. 2003, Bucknell University. 1.
[Show full text]
THE CASE for FIRST AMENDMENT PROTECTION of BIOART in 2000
FREEDOM TO EXPRESS A BIOLOGICAL CONSTRUCT: THE CASE FOR FIRST AMENDMENT PROTECTION OF BIOART KEITH SYVERSON INTRODUCTION In 2000, contemporary artist Eduardo Kac made international headlines by partnering with scientists at the Institut National de la Recherche Agronomique (INRA), France where together they genetically engineered an albino rabbit to express an enhanced green fluorescent protein (GFP)1 so that the rabbit would glow green when exposed to blue light.2 The entire project from its conception to the final display was intended as an artistic experiment to challenge society’s views on animal experimentation and the selective breeding of pets.3 This type of work that merges art and biology is called “BioArt.” According to Eduardo Kac, BioArt “employs one or more of the following approaches: (1) the coaching of biomaterials into specific inert shapes or behaviors; (2) the unusual or subversive use of biotech tools and processes; (3) the invention or transformation of living organisms with or without social environmental integration."4 BioArt has arguably existed for centuries.5 For example, some commentators have described the primitive methods of brewing beer in the Old Kingdom as form of BioArt.6 Similarly, the artificial selection involved in agriculture has been viewed by some as a form of 1 Frances Stracey, Bio-art: The Ethics Behind the Aesthetics, 10 NATURE REVIEWS: MOLECULAR CELL BIOLOGY 496, 499 (2009). 2 Id. 3 Id. 4 Eduardo Kac, Art That Looks You in the Eye: Hybrids, Clones, Mutants, Synthetics, and Transgenics, in SIGNS OF LIFE 1, 18 (Eduardo Kac ed., MIT Press, 2007). 5 See Edgar DaSilva, Art, Biotechnology and the Culture of Peace, 7 ELECTRONIC JOURNAL OF BIOTECHNOLOGY 130, 131-32 (2004) (arguing that the brewing reliefs in Egypt during the Old Kingdom from 2650 BC are an example of BioArt).
[Show full text]
Combatting Monsanto
Picture: Grassroots International Combatting Monsanto Grassroots resistance to the corporate power of agribusiness in the era of the ‘green economy’ and a changing climate La Via Campesina, Friends of the Earth International, Combat Monsanto Technical data name: “Combatting Monsanto Grassroots resistance to the corporate power of agribusiness in the era of the ‘green economy’ and a changing climate” author: Joseph Zacune ([email protected]) with contributions from activists around the world editing: Ronnie Hall ([email protected]) design and layout: Nicolás Medina – REDES-FoE Uruguay March 2012 Combatting Monsanto Grassroots resistance to the corporate power of agribusiness in the era of the ‘green economy’ and a changing climate INDEX Executive summary / 2 Company profile - Monsanto / 3 Opposition to Monsanto in Europe / 5 A decade of French resistance to GMOs / 6 Spanish movements against GM crops / 9 German farmers’ movement for GM-free regions / 10 Organising a movement for food sovereignty in Europe / 10 Monsanto, Quit India! / 11 Bt brinjal and biopiracy / 11 Bt cotton dominates cotton sector / 12 Spiralling debt still triggering suicides / 12 Stopping Monsanto’s new public-private partnerships / 13 Resistance to Monsanto in Latin America / 14 Brazilian peasant farmers’ movement against agribusiness / 14 Ten-year moratorium on GM in Peru / 15 Landmark ruling on toxic soy in Argentina / 15 Haitians oppose seed aid / 16 Guatemalan networks warn of new biosafety proposals / 17 Battle-lines drawn in the United States / 17 Stopping the
[Show full text]
General Court of the European Union PRESS RELEASE No 160/13 Luxembourg, 13 December 2013
General Court of the European Union PRESS RELEASE No 160/13 Luxembourg, 13 December 2013 Judgment in Case T-240/10 Press and Information Hungary v Commission The General Court has annulled the Commission’s decisions concerning authorisation to place on the market the genetically modified potato Amflora The Commission infringed the procedural rules of the systems for authorising GMOs in the European Union In the territory of the European Union, genetically modified organisms (GMOs) may be released into the environment or placed on the market only if consent has been given, subject to specific conditions and granted with a view to specified uses, after a scientific assessment of the risks. The authorisation system consists of two different procedures which are applied depending on the intended use of the GMOs. The aim of the first procedure, whose rules are laid down by Directive 2001/18/EC1, is to authorise GMOs with a view to their deliberate release into the environment. Within the framework of that procedure, it is in principle for the Member State with which an undertaking has lodged an application for this purpose to issue consent. However, the other Member States, and also the Commission, may raise objections vis-à-vis the intended consent decision. The second authorisation procedure, set up by Regulation 1829/20032, concerns genetically modified food and feed. In that case, the application for consent is assessed at EU level. Where, in the context of the first procedure, an objection has been raised or, in the context of the second procedure, an application for consent has been submitted, the final decision on the authorisation is taken by the Commission or by the Council on the basis of the scientific opinions of the European Food Safety Authority (EFSA).
[Show full text]
10 Harvard Mouse
The Harvard Mouse or the transgenetic technique Term Paper Biology Georgina Cibula, 4e LIST of Contents Preface What is my motivation to work on the chosen topic? What is especially interesting? What are our questions with respects to the chosen topic? Introduction What is the context of the chosen topic? What is the recent scientific history? Where and why is the technique used? Are there alternatice treatments? Description of engineering technique No institution visited Discussion What progress was made with the application of the chosen technique? What future research steps? Ethical aspects Summary References PREFACE What is my motivation to work on the chosen topic? There are many reasons. One of them is that it’s a very interesting topic. It is fascinating, how you can increase or decrease the functionality of organisms. What is especially interesting? The intricacy. And that you can use the method not only for mice but for every organism. For example in the Green genetic engineering (to make plants more resistant) or for pharmaceuticals like human insulin. Some genes are responsible for the aging process. So if we can find those genes and deactivate them we would life longer. First successful experiments with animals where already made. What I also like about this topic is the big ethic question behind it. I mean in the end we use animals, often mice because of their similarity to our genes, to benefit of them. We intentional make them ill and lock them into small cages. But on the other hands medicaments can be tested or invented which can save many human lifes.
[Show full text]
Genetically Modified, Red Fluorescent Zebrafish: Detection, Crossing
Journal of Environmental Biotechnology Vol. 8, No. 2, 105–110, 2008 Original paper (regular paper) Genetically Modifi ed, Red Fluorescent Zebrafi sh: Detection, Crossing, Inheritance of Red Fluorescence, and Tolerance to Low Temperatures KIMIKO AMANUMA*, NOBUYOSHI NAKAJIMA, AKIKO H. HASHIMOTO and YASUNOBU AOKI National Institute for Environmental Studies, 16–2 Onogawa, Tsukuba, Ibaraki 305–8506, Japan * TEL: +81–(0)29–850–2390 FAX: +81–(0)29–850–2588 * E-mail: [email protected] (Received; 28 September, 2008/Accepted; 10 October, 2008) Under Cartagena Protocol domestic law, genetically modifi ed (GM) fi sh have not yet received permission to be imported or sold in Japan. However, it is anticipated that ornamental, fl uorescent GM fi sh will be imported and sold prior to any offi cial process for evaluating their eff ects on biological diversity as GM organisms (GMO). Therefore, we have devised a method for detecting GM fi sh that utilizes PCR for the detection of replication origins of plasmids that generally exist as transgenes integrated in the GMOs’ chromosomes. Using red fl uorescent zebrafi sh (rfZF), sold in Japan, and rpsL GM ZF established by us, we demonstrated the feasibility of this method for detecting GMO. Next, we examined the biological characteristics of the GM rfZF. They were able to cross with non-GM ZF; the red fl uorescence was inherited by their progeny according to expected outcomes, based on Mendelian genetics. Examination of the low temperature tolerance of rfZF and non-GM fi sh indicated that the lethal, minimum temperature was the same for both fi sh (5°C).
[Show full text]
University-Industry Partnerships and the Licensing of the Harvard Mouse
PATENTS Managing innovation: university-industry partnerships and the licensing of the Harvard mouse Sasha Blaug1,Colleen Chien1 & Michael J Shuster DuPont’s Oncomouse patent licensing program continues to cause a stir in academia and industry. ver the last several decades, technology restructuring in the 1980s resulting in optimized for mutual near- and long-term Oand technological innovation have reduced industry R&D spending and scarcer benefits to the parties? Recently this dialog gradually replaced manufacturing and agri- federal R&D funding. Increased technology has been focused on DuPont’s licensing of culture as the main drivers of the US econ- transfer has sparked a debate on univ- the transgenic ‘Harvard mouse,’ subse- omy. The unparalleled system of American ersities’ roles in the national economy: on quently trademarked as the Oncomouse6. research universities1 and their association the extent to which these relationships affect http://www.nature.com/naturebiotechnology with industry are important drivers of the the mission of universities to carry out The Oncomouse patents new economy. The relationship between and disseminate the results of basic DuPont’s patent licensing program for universities and industry is multifaceted, research, and on how universities can man- ‘Oncomouse technology’ has caused a stir in encompassing exchanges of knowledge, age their partnerships, collaborations and academia and industry for over a decade7. expertise, working culture and money. technology transfer without compromising These patents broadly claim transgenic Whereas the transfer of technology from their mission. nonhuman mammals expressing cancer- universities to industry has been going on In the basic research paradigm, inves- promoting oncogenes, a basic research tool for more than a century, ties between uni- tigators’ inquiries are directed toward dev- widely used in the fight against cancer.
[Show full text]
Genome As a Tool of Genetic Engineering: Application in Plant and Plant Derived Medicine
International Journal of Biotech Trends and Technology (IJBTT) – Volume 8 Issue 1- Jan - March 2018 Genome as a Tool of Genetic Engineering: Application in Plant and Plant Derived Medicine A.B.M. Sharif Hossain1,2 Musamma M. Uddin2 1Department of Biology, Faculty of Science, Hail University, Hail, KSA 2Biotechnology Program, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia introduce point mutations. Genetically modified Abstract organism (GMO) is considered as an organism that The study was conducted from different is generated through genetic engineering. The first modern research data to review the innovative GMOs were bacteria in 1973, GM mice were generated in 1974 [4]. Insulin-producing bacteria latest technology in the genomics and its were commercialized in 1982 and genetically application in Agriculture, biomedicinae and modified food has been sold since 1994. Glofish, the plant derived medicine. Application of genome first GMO designed as a pet, was first sold in the in genetic engineering and molecular United States December in 2003 [4]. Genetic biotechnology have been exhibited well. engineering biotechnology has been applied in Genetically Modified Organism (GMO), numerous fields including agriculture, industrial Agrobacterium mediated recombination (T- biotechnology, and medicine. Enzymes used in DNA) and genetic engineering using molecular laundry detergent and medicines such as insulin and Biotechnology in plant, medicine and human growth hormone are now manufactured in biomedicine have been highlighted from GM cells, experimental GM cell lines and GM animals such as mice or zebra fish are being used for technology based different research data. research purposes, and genetically modified Moreover, molecular biotechnology in crops have been commercialized [4].
[Show full text]
The Bio Revolution: Innovations Transforming and Our Societies, Economies, Lives
The Bio Revolution: Innovations transforming economies, societies, and our lives economies, societies, our and transforming Innovations Revolution: Bio The The Bio Revolution Innovations transforming economies, societies, and our lives May 2020 McKinsey Global Institute Since its founding in 1990, the McKinsey Global Institute (MGI) has sought to develop a deeper understanding of the evolving global economy. As the business and economics research arm of McKinsey & Company, MGI aims to help leaders in the commercial, public, and social sectors understand trends and forces shaping the global economy. MGI research combines the disciplines of economics and management, employing the analytical tools of economics with the insights of business leaders. Our “micro-to-macro” methodology examines microeconomic industry trends to better understand the broad macroeconomic forces affecting business strategy and public policy. MGI’s in-depth reports have covered more than 20 countries and 30 industries. Current research focuses on six themes: productivity and growth, natural resources, labor markets, the evolution of global financial markets, the economic impact of technology and innovation, and urbanization. Recent reports have assessed the digital economy, the impact of AI and automation on employment, physical climate risk, income inequal ity, the productivity puzzle, the economic benefits of tackling gender inequality, a new era of global competition, Chinese innovation, and digital and financial globalization. MGI is led by three McKinsey & Company senior partners: co-chairs James Manyika and Sven Smit, and director Jonathan Woetzel. Michael Chui, Susan Lund, Anu Madgavkar, Jan Mischke, Sree Ramaswamy, Jaana Remes, Jeongmin Seong, and Tilman Tacke are MGI partners, and Mekala Krishnan is an MGI senior fellow.
[Show full text]
11:115:321 (44K PDF)
Ethical Issues in Biochemical Research Spring 2021 11:115:321:01 George Pieczenik, Ph.D., Professor Spring 2021 Day M,W Time 2:15-3:35 Online: GoToMeeting and Zoom 3 credits, meeting twice a week for 80 minutes Course Description This course will address ethical issues in biochemistry, with some focus on genetics and molecular biology. The course will consist of lectures by the professor, as well as student presentations on selected topics. Issues to be covered will include the ethics of recombinant DNA technology, of genetically modified plants and animals, of stem cell use, scientific patents, and of creating DNA databases. Other topics will include the political use of genetics and evolutionary paradigms, and the use of fraudulent data and “pseudo science”, and how these tools can be used to sway public opinion. Important issues facing scientists and students currently will also be discussed, such as plagiarism . data manipulation and consequences of the biotechnology revolution. Course Requirements 1. Class Attendance & Participation: Students are expected to attend class online and to participate actively. There will be spot quizzes. Unexcused absences (>3) will result in failure. (10%) Online class attendance will be through GoToMyMeeting and/or Zoom. Classes will be recorded and deposited to Dropbox for students who can not make the class synchronously. 2. Essays on assigned topics: Students will present two power point topics assigned or requested. for presentation to the class. (70%) 3. Final exam; A final take home 2 hour exam. (20%) Optional reading list from which to prepare paper The Main text is Edwin Black's - America's War on the Weak Publisher: Four Walls Eight Windows; (September 2003) ISBN: 1568582587 Rosalind Franklin: The Dark Lady of DNA by Brenda Maddox , Harper Collins 2002, UK The Fraud of Abderhalden’s Enzymes by Ute Deichmann and Benno Muller-Hill, Nature vol 393.
[Show full text]
Organic Farming Dwarfs GM Crop Production in Europe
for the people | for the planet | for the future Organic farming dwarfs GM crop production in Europe February 2012 The area dedicated to growing genetically modified (GM) crops in the European Union remains insignificant when compared with conventional and organic farming. In 2011, GM crops were grown on 0.1% of arable land in Europe, compared with nearly 4% for organic. Nineteen member states cultivated no GM crops at all. The EU has 110,849,000 hectares of arable land (excluding permanent crops as vineyards), of which only 114,525 hectares were planted with GM crops in 2011. Table 1: GMO cultivation in European countries, 2008-2011 Country and crops 2008(ha) 2009(ha) 2010(ha) 2011(ha) Cultivation of Maize Mon810 Spain (1) 79,269 76,057 67,726 97,346 Portugal (2) 4,856 5,202 4,869 7,723 Czech Republic (3) 8,380 6,480 4,830 5,090 Poland (4) 3,000 3,000 3000 3,000 Slovakia (5) 1,931 875 1,248 760 Romania (6) 6,130 3,244 823 588 Germany (7) 3,173 0 0 0 Cultivation of potato Amflora Sweden (8) 0 0 103 16 Germany (9) 0 0 15 2 106,739 94,858 82,614 114,525 The main exception to this picture of GM crop rejection in Europe is Spain where 97,346 hectares of Monsanto’s maize were planted in 2011. The increase was mainly caused by the general expansion of the area cultivated with maize from 311,900 (21.7% GM) to 368,300 (26.4% GM) hectares.
[Show full text]
Guide to Biotechnology 2008
guide to biotechnology 2008 research & development health bioethics innovate industrial & environmental food & agriculture biodefense Biotechnology Industry Organization 1201 Maryland Avenue, SW imagine Suite 900 Washington, DC 20024 intellectual property 202.962.9200 (phone) 202.488.6301 (fax) bio.org inform bio.org The Guide to Biotechnology is compiled by the Biotechnology Industry Organization (BIO) Editors Roxanna Guilford-Blake Debbie Strickland Contributors BIO Staff table of Contents Biotechnology: A Collection of Technologies 1 Regenerative Medicine ................................................. 36 What Is Biotechnology? .................................................. 1 Vaccines ....................................................................... 37 Cells and Biological Molecules ........................................ 1 Plant-Made Pharmaceuticals ........................................ 37 Therapeutic Development Overview .............................. 38 Biotechnology Industry Facts 2 Market Capitalization, 1994–2006 .................................. 3 Agricultural Production Applications 41 U.S. Biotech Industry Statistics: 1995–2006 ................... 3 Crop Biotechnology ...................................................... 41 U.S. Public Companies by Region, 2006 ........................ 4 Forest Biotechnology .................................................... 44 Total Financing, 1998–2007 (in billions of U.S. dollars) .... 4 Animal Biotechnology ................................................... 45 Biotech
[Show full text]